S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MYNZ Mainz BioMed NV

0.8799

0.0129 (1.49%)

After Hours

Last Updated: 07:25:56

Delayed by 15 minutes

Mainz Biomed more than doubles on trading debut

To read the full story on Seeking Alpha, click here.

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Mainz BioMed NV Charts.

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Mainz BioMed NV Charts.

Mainz BioMed BV News

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
Thursday 25 April 2024 (5 days ago) • GlobeNewswire Inc.

Mainz Biomed Reports Full Year 2023 Financial Results
Tuesday 9 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
Monday 18 March 2024 (1 month ago) • GlobeNewswire Inc.

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
Friday 12 January 2024 (4 months ago) • GlobeNewswire Inc.

Mainz Biomed Provides Year-End Corporate Review 2023
Wednesday 10 January 2024 (4 months ago) • GlobeNewswire Inc.

More Mainz BioMed BV News Articles

Commonwealth Bank Of Aus...

AUD vs US Dollar

Australian SE All Ordina...

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions